Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-010828
Filing Date
2016-01-05
Accepted
2016-01-05 16:05:25
Documents
1
Period of Report
2016-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4037
  Complete submission text file 0000899243-16-010828.txt   5504
Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Issuer) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 46668 CRAWFORD CT. FREMONT CA 94539
Business Address
McKune John (Reporting) CIK: 0001650427 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 161322099